title: Helper-dependent adenoviral vectors for liver-directed gene therapy.
abstract: Helper-dependent adenoviral (HDAd) vectors devoid of all viral-coding sequences are promising non-integrating vectors for liver-directed gene therapy because they have a large cloning capacity, can efficiently transduce a wide variety of cell types from various species independent of the cell cycle and can result in long-term transgene expression without chronic toxicity. The main obstacle preventing clinical applications of HDAd for liver-directed gene therapy is the host innate inflammatory response against the vector capsid proteins that occurs shortly after intravascular vector administration resulting in acute toxicity, the severity of which is dependent on vector dose. Intense efforts have been focused on elucidating the factors involved in this acute response and various strategies have been investigated to improve the therapeutic index of HDAd vectors. These strategies have yielded encouraging results with the potential for clinical translation.
authors.affiliation: Telethon Institute of Genetics and Medicine, Naples 80131, Italy.
authors.forename: Nicola
authors.initials: N
authors.lastname: Brunetti-Pierri
authors.forename: Philip
authors.initials: P
authors.lastname: Ng
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D006378:Helper Viruses / Q000235:genetics*; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D008099:Liver / Q000166:cytology* / Q000378:metabolism; D008107:Liver Diseases / Q000628:therapy*; D014161:Transduction, Genetic; D019076:Transgenes